Gene therapy is hardly flavor of the month for investors at the moment but that has not stopped SpliceBio from signing off the largest ever series A financing in Spain for a biotech company.
SpliceBio has completed an oversubscribed €50m finance round co-led by UCB Ventures and existing shareholder Ysios Capital